I found another article on the '$500m life sciences fund' that gives additional quotes from JCC.
...Jeremy Curnock Cook, the managing director of BioScience Managers said, “What is required is not just more money but an investment approach that ensures that companies can access the right people and expertise to give their biomedical innovation the best chance to succeed in a highly competitive world market.”
“We really need to ensure that the next generation of companies like Cochlear, Resmed and CSL can grow and flourish from Australia and become international champions, and this investment capital will certainly go a long way to ensuring that,” he adds.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)